 |
Journal articles
Red blood cell alloimmunization in sickle cell disease: pathophysiology, risk factors, and transfusion management.
Abstract : Red blood cell transfusions have reduced morbidity and mortality for patients with sickle cell disease. Transfusions can lead to erythrocyte alloimmunization, however, with serious complications for the patient including life-threatening delayed hemolytic transfusion reactions and difficulty in finding compatible units, which can cause transfusion delays. In this review, we discuss the risk factors associated with alloimmunization with emphasis on possible mechanisms that can trigger delayed hemolytic transfusion reactions in sickle cell disease, and we describe the challenges in transfusion management of these patients, including opportunities and emerging approaches for minimizing this life-threatening complication.
Cited literature [97 references]
https://www.hal.inserm.fr/inserm-00696264
Contributor : Georges Guellaen Connect in order to contact the contributor
Submitted on : Sunday, November 11, 2012 - 7:00:03 AM
Last modification on : Tuesday, October 19, 2021 - 4:09:32 PM
Long-term archiving on: : Tuesday, February 12, 2013 - 2:20:10 AM
Contributor : Georges Guellaen Connect in order to contact the contributor
Submitted on : Sunday, November 11, 2012 - 7:00:03 AM
Last modification on : Tuesday, October 19, 2021 - 4:09:32 PM
Long-term archiving on: : Tuesday, February 12, 2013 - 2:20:10 AM